Published in Eur J Pharmacol on January 28, 1992
Cellular basis of memory for addiction. Dialogues Clin Neurosci (2013) 1.15
Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biol Psychiatry (2008) 1.14
Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol Psychiatry (2009) 1.09
Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons. Proc Natl Acad Sci U S A (2010) 1.07
The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res (2009) 1.06
Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci U S A (1994) 0.97
Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons. Cold Spring Harb Perspect Med (2012) 0.96
Pre- and postsynaptic regulation of locus coeruleus neurons after chronic morphine treatment: a study of GIRK-knockout mice. Eur J Neurosci (2008) 0.88
Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine. Proc Natl Acad Sci U S A (2003) 0.86
Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.83
Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function". Brain Res (2015) 0.81
Galanin negatively modulates opiate withdrawal via galanin receptor 1. Psychopharmacology (Berl) (2011) 0.81
Opioids inhibit visceral afferent activation of catecholamine neurons in the solitary tract nucleus. Neuroscience (2012) 0.80
Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.80
Morphine administration and abrupt cessation alter the behavioral diurnal activity pattern. Pharmacol Biochem Behav (2012) 0.76
Increased opioid dependence in a mouse model of panic disorder. Front Behav Neurosci (2010) 0.75
Direct Facilitatory Role of Paragigantocellularis Neurons in Opiate Withdrawal-Induced Hyperactivity of Rat Locus Coeruleus Neurons: An In Vitro Study. PLoS One (2015) 0.75
Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus. Psychopharmacology (Berl) (2015) 0.75
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci (2000) 9.12
A molecular and cellular theory of depression. Arch Gen Psychiatry (1997) 6.10
Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29
Regulation of cocaine reward by CREB. Science (1998) 4.07
Molecular and cellular basis of addiction. Science (1997) 3.57
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci (1996) 3.33
Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci (2001) 3.09
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature (2001) 3.09
Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature (1978) 2.85
Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci (1997) 2.69
Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science (1996) 2.68
Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61
Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med (2000) 2.61
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53
Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A (1992) 2.49
Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A (2000) 2.39
Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci (1999) 2.36
Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J Neurosci (2001) 2.30
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse (1987) 2.20
Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience (2003) 2.19
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci U S A (1997) 1.98
The formation of synaptic junctions in developing rat brain: a quantitative electron microscopic study. Brain Res (1967) 1.90
Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature (1998) 1.88
Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse (2008) 1.87
The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci (1997) 1.84
A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res (1991) 1.84
Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci (1996) 1.82
Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res (1983) 1.82
Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci (1996) 1.80
Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry (1996) 1.79
Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci (1998) 1.70
Distribution of protein I in mammalian brain as determined by a detergent-based radioimmunoassay. Proc Natl Acad Sci U S A (1981) 1.70
alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science (1982) 1.65
Carbon dioxide regulates the tonic activity of locus coeruleus neurons by modulating a proton- and polyamine-sensitive inward rectifier potassium current. Neuroscience (1997) 1.63
Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain. Brain Res Mol Brain Res (2000) 1.62
Sensitization to morphine induced by viral-mediated gene transfer. Science (1997) 1.62
Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci (1997) 1.62
Physiological evidence for habenula as major link between forebrain and midbrain raphe. Science (1977) 1.61
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Protein phosphorylation in the brain. Nature (1983) 1.60
Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther (1995) 1.60
Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci (1995) 1.59
Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation. Neuroscience (2007) 1.59
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther (2000) 1.58
Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol (1998) 1.58
Fine structural and cytochemical analysis of the staining of synaptic junctions with phosphotungstic acid. J Ultrastruct Res (1968) 1.56
Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature (1971) 1.55
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend (1998) 1.53
Dopamine and depolarizing agents regulate the state of phosphorylation of protein I in the mammalian superior cervical sympathetic ganglion. Proc Natl Acad Sci U S A (1980) 1.51
Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A (1996) 1.49
Serotonin receptors in the brain. Fed Proc (1977) 1.46
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol Pharmacol (1995) 1.44
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
Serotonergic facilitation of facial motoneuron excitation. Brain Res (1979) 1.41
Modulation of a transient outward current in serotonergic neurones by alpha 1-adrenoceptors. Nature (1985) 1.40
Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res (1975) 1.40
Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.39
CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci (1997) 1.38
Cytochemistry of synapses: selective staining for electron microscopy. Science (1966) 1.38
Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci (1999) 1.37
Intracellular studies showing modulation of facial motoneurone excitability by serotonin. Nature (1980) 1.36
Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci (1995) 1.36
Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci (1990) 1.34
Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res (1978) 1.32
Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res (2003) 1.31
Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol (1978) 1.31
Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol (1977) 1.31
Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol (1996) 1.30
Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem (2001) 1.29
Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci (1997) 1.28
Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1. J Neurosci (2000) 1.28
Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J Pharmacol Exp Ther (1994) 1.28
Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology (1980) 1.27
Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse (1995) 1.27
5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol (1999) 1.26
Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res (1997) 1.26
Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res (1991) 1.26
Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci (1976) 1.25
Molecular mechanisms of psychostimulant-induced structural plasticity. Pharmacopsychiatry (2009) 1.25
Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol (2000) 1.24
Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci (1998) 1.24
Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther (1988) 1.23
Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol (1974) 1.21
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience (2006) 1.21
Neuronal phosphoproteins: physiological and clinical implications. Science (1984) 1.21
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci (1996) 1.20
Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem (1991) 1.20
Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther (1970) 1.20
Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci I (1972) 1.20
Endogenous ADP-ribosylation in brain: initial characterization of substrate proteins. J Neurochem (1991) 1.20
5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci (1997) 1.19
Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology (1988) 1.19
Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience (1995) 1.19
Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology (1996) 1.18